Corvino Frank 4
4 · HEALTHEQUITY, INC. · Filed Sep 26, 2023
Insider Transaction Report
Form 4
Corvino Frank
Director
Transactions
- Sale
Common Stock
2023-09-22$72.23/sh−1,455$105,094→ 7,293 total - Sale
Common Stock
2023-09-22$72.29/sh−3,608$260,830→ 8,748 total - Exercise/Conversion
Stock Option (right to buy)
2023-09-22−3,608→ 0 totalExercise: $14.00Exp: 2024-07-30→ Common Stock (3,608 underlying) - Exercise/Conversion
Common Stock
2023-09-22$14.00/sh+3,608$50,512→ 12,356 total
Holdings
- 6,482
Stock Option (right to buy)
Exercise: $21.27Exp: 2026-02-01→ Common Stock (6,482 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.27 to $72.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.21 to $72.25 inclusive.
- [F3]The option is immediately exercisable.